Arete Wealth Advisors LLC Purchases New Position in HCA Healthcare, Inc. (NYSE:HCA)

Posted by Defense World Staff on Sep 17th, 2023

Arete Wealth Advisors LLC acquired a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,890 shares of the company’s stock, valued at approximately $498,000.

Several other institutional investors and hedge funds also recently bought and sold shares of HCA. James Investment Research Inc. bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $31,000. Concord Wealth Partners grew its stake in shares of HCA Healthcare by 54.1% during the first quarter. Concord Wealth Partners now owns 151 shares of the company’s stock valued at $40,000 after buying an additional 53 shares during the last quarter. Covestor Ltd increased its stake in HCA Healthcare by 122.7% in the 1st quarter. Covestor Ltd now owns 167 shares of the company’s stock worth $42,000 after buying an additional 92 shares during the period. Osterweis Capital Management Inc. purchased a new position in HCA Healthcare in the 4th quarter worth about $44,000. Finally, Scissortail Wealth Management LLC purchased a new position in HCA Healthcare in the 1st quarter worth about $315,475,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Jeffrey E. Cohen sold 1,500 shares of HCA Healthcare stock in a transaction on Friday, August 11th. The shares were sold at an average price of $270.00, for a total value of $405,000.00. Following the completion of the transaction, the senior vice president now owns 4,414 shares of the company’s stock, valued at $1,191,780. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, SVP Jeffrey E. Cohen sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, August 11th. The stock was sold at an average price of $270.00, for a total transaction of $405,000.00. Following the completion of the transaction, the senior vice president now directly owns 4,414 shares of the company’s stock, valued at approximately $1,191,780. The sale was disclosed in a filing with the SEC, which is available at this link. Also, SVP Kathryn A. Torres sold 5,204 shares of the company’s stock in a transaction that occurred on Monday, August 14th. The stock was sold at an average price of $269.12, for a total value of $1,400,500.48. Following the transaction, the senior vice president now directly owns 19,760 shares of the company’s stock, valued at $5,317,811.20. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,620 shares of company stock valued at $2,592,820. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Down 2.8 %

HCA stock opened at $256.28 on Friday. The firm’s fifty day simple moving average is $276.42 and its 200-day simple moving average is $273.88. The company has a market capitalization of $69.71 billion, a P/E ratio of 12.61, a price-to-earnings-growth ratio of 1.35 and a beta of 1.60. The company has a debt-to-equity ratio of 79.26, a current ratio of 1.20 and a quick ratio of 1.03. HCA Healthcare, Inc. has a 12 month low of $178.32 and a 12 month high of $304.86.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings data on Thursday, July 27th. The company reported $4.29 EPS for the quarter, beating the consensus estimate of $4.28 by $0.01. The business had revenue of $15.86 billion for the quarter, compared to the consensus estimate of $15.63 billion. HCA Healthcare had a net margin of 9.32% and a negative return on equity of 12,765.76%. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm earned $4.21 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 18.44 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be issued a $0.60 dividend. The ex-dividend date is Thursday, September 14th. This represents a $2.40 dividend on an annualized basis and a yield of 0.94%. HCA Healthcare’s payout ratio is 11.81%.

Analyst Ratings Changes

Several equities research analysts have weighed in on HCA shares. Barclays upped their target price on HCA Healthcare from $275.00 to $300.00 in a report on Wednesday, June 28th. Oppenheimer upped their target price on HCA Healthcare from $310.00 to $315.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, September 12th. Credit Suisse Group increased their price objective on shares of HCA Healthcare from $311.00 to $316.00 and gave the company an “outperform” rating in a research note on Friday, July 28th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $315.00 target price on shares of HCA Healthcare in a research note on Thursday. Two analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $310.86.

Read Our Latest Analysis on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, provides health care services in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.